Related references
Note: Only part of the references are listed.
Article
Ophthalmology
Amirreza Veisi et al.
Summary: This report presents two cases of COVID-19 patients treated with corticosteroid developing mucormycosis, emphasizing the importance of prompt diagnosis and management.
EUROPEAN JOURNAL OF OPHTHALMOLOGY
(2022)
Article
Ophthalmology
Liane O. Dallalzadeh et al.
Summary: Two fatal cases of rhino-orbital-cerebral mucormycosis associated with COVID-19 infection were reported, both rapidly declining and extending into the intracranial cavity. The role of ophthalmologists is crucial in early diagnosis of COVID-19 related mucormycosis.
ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY
(2022)
Article
Emergency Medicine
Amanda Werthman-Ehrenreich
Summary: During the COVID-19 pandemic, various manifestations and complications have emerged, including acute cardiac injury, arrhythmias, thromboembolic complications, and secondary infections. Early recognition of these high morbidity conditions is crucial for optimal treatment and improved outcomes.
AMERICAN JOURNAL OF EMERGENCY MEDICINE
(2021)
Article
Medicine, Research & Experimental
Andre K. Johnson et al.
Summary: Invasive pulmonary mucormycosis and aspergillosis are rare and life-threatening fungal infections, often seen in patients with diabetes, neutropenia, or corticosteroid use. These infections are recognized as secondary complications of COVID-19, particularly in critically ill patients. This report presents the first case of combined probable pulmonary aspergillosis and possible mucormycosis in a male with COVID-19 in the ICU.
MEDICAL MYCOLOGY CASE REPORTS
(2021)
Article
Otorhinolaryngology
Wael F. Ismaiel et al.
Summary: The incidence of AIFRS is significantly higher in post-COVID-19 patients, especially in immunocompromised, diabetic, renal, and liver dysfunction patients as well as those with risk factors for rhinosinusitis, compared to non-COVID-19 patients. Common organisms affecting patients with AIFRS include Rhizopus oryzae, Aspergillus fumigatus, and Absidia mucor.
AMERICAN JOURNAL OF OTOLARYNGOLOGY
(2021)
Review
Infectious Diseases
Valliappan Muthu et al.
Summary: The study aimed to assess the mortality and trend of pulmonary mucormycosis (PM) in immunocompromised patients. Results showed that mortality of PM has improved over time, with combined medical-surgical therapy associated with lower mortality risk than medical treatment alone. Risk of death was higher in disseminated disease compared to isolated PM, while diabetes mellitus was not associated with higher mortality risk.
CLINICAL MICROBIOLOGY AND INFECTION
(2021)
Article
Ophthalmology
Zesemayat K. Mekonnen et al.
Summary: Acute invasive fungal rhinosinusitis is a rare and dangerous infection primarily affecting immunosuppressed individuals, with COVID-19 patients being particularly susceptible to fungal coinfections. Prompt recognition and treatment of fungal infections are crucial for improving patient survival.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY
(2021)
Review
Dermatology
Kazem Ahmadikia et al.
Summary: Acute respiratory distress syndrome is a common complication of severe viral pneumonia, requiring critical care with corticosteroids, but steroid therapy can lead to secondary fungal infections, with diabetes being a risk factor for mucormycosis.
Letter
Otorhinolaryngology
Mahboobeh Karimi-Galougahi et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY
(2021)
Article
Microbiology
Anubhav Kanwar et al.
Summary: This case report highlights a rare case of COVID-19 patient with Rhizopus azygosporus pneumonia, emphasizing the potential risk of mucormycosis with the use of immunosuppressants. It underscores the importance of vigilance in monitoring hospitalized COVID-19 patients for fungal infections.
Article
Microbiology
Christoph Zurl et al.
Summary: Viral infections can lead to ARDS and increase the risk of secondary pulmonary infections. Several studies have reported cases of severe COVID-19 complicated by secondary pulmonary aspergillosis.
Article
Otorhinolaryngology
S. Sharma et al.
Summary: A study found an association between coronavirus disease and fungal infection of the paranasal sinuses, with ethmoids being the most commonly affected sinuses. Intra-orbital extension occurred in 43.47% of cases, while intracranial extension was seen in only 8.69% of cases. Twenty-one out of 23 patients had diabetes mellitus, with 12 cases being uncontrolled, and all patients had a history of steroid use during their coronavirus treatment.
JOURNAL OF LARYNGOLOGY AND OTOLOGY
(2021)
Article
Medicine, Research & Experimental
Noha Ahmed El-Kholy et al.
Summary: Invasive fungal respiratory superinfections in patients with COVID-19 have gained attention, but acute invasive fungal sinusitis in these patients remains poorly described. This study aimed to address this gap, showing that early suspicion and management of acute invasive fungal sinusitis among COVID-19 patients can lead to better outcomes and higher survival rates.
Review
Mycology
Akshay Khatri et al.
Summary: This case report describes a rare occurrence of mucormycosis following COVID-19 in a heart transplant recipient, highlighting the potential mechanisms by which COVID-19 may predispose individuals to invasive fungal infections. Despite aggressive therapeutic measures, the patient ultimately succumbed to the infection. The study also emphasizes the need for clinicians to be vigilant in evaluating for invasive fungal infections like mucormycosis in patients with COVID-19.
JOURNAL DE MYCOLOGIE MEDICALE
(2021)
Article
Dermatology
Farzad Pakdel et al.
Summary: This study reported clinical features, contributing factors and outcome of patients with COVID-19-associated mucormycosis (CAM). Among the 15 patients observed, majority were male with a median age of 52 years, and most had diabetes mellitus. Patients who received combined antifungal therapy did not experience mortality, while nearly half of the patients died from mucormycosis.
Article
Dermatology
Shivaprakash M. Rudramurthy et al.
Summary: Globally, the incidence of COVID-19-associated mucormycosis (CAM) is rising, with a significant surge in India. The need to address misconceptions in managing and treating this infection is crucial, with a focus on early suspicion, diagnosis confirmation, glycemic control, surgical debridement, and antifungal therapy. Limited availability of amphotericin B formulations during the epidemic has led to discussions on alternative antifungal therapies.
Letter
Immunology
Hari S. Meshram et al.
TRANSPLANT INFECTIOUS DISEASE
(2021)
Review
Immunology
Carolt Arana et al.
Summary: COVID-19 predisposes patients to bacterial and fungal superinfections by impairing the immune system, with mucormycosis being one of the least common but highest mortality opportunistic fungal infections. We present two cases of mucormycosis in kidney transplant recipients hospitalized for SARS-CoV-2 pneumonia, involving rhinosinusal and musculoskeletal areas, respectively.
TRANSPLANT INFECTIOUS DISEASE
(2021)
Letter
Infectious Diseases
A. -P. Bellanger et al.
INFECTIOUS DISEASES NOW
(2021)
Article
Immunology
Atul Patel et al.
Summary: This study found an increase in mucormycosis cases in India during the COVID-19 pandemic, mainly due to inappropriate glucocorticoid use, resulting in a higher mortality rate among mucormycosis patients.
EMERGING INFECTIOUS DISEASES
(2021)
Article
Infectious Diseases
Vidya Krishna et al.
Summary: Mucormycosis is more commonly reported than Aspergillosis as a secondary fungal infection in COVID-19 cases. This case study highlights the unique challenge of diagnosing and treating mucormycosis in critically ill patients with COVID-19, especially in immunocompetent hosts.
Article
Immunology
Hardeva Ram Nehara et al.
Summary: COVID-19 patients may experience a wide range of clinical manifestations and complications, as well as an increased risk of serious infections such as mucormycosis. Early recognition and treatment are crucial for ensuring optimal outcomes.
INDIAN JOURNAL OF MEDICAL MICROBIOLOGY
(2021)
Article
Surgery
Aastha Maini et al.
Summary: This case report details a post COVID-19 Sino-orbital Mucormycosis infection caused by Rhizopus oryzae and its management. Mucormycosis typically develops secondary to immunosuppression or debilitating diseases, highlighting the importance of early diagnosis and intervention for a good prognosis. Research is needed on COVID-19 patients for better prevention and management of opportunistic infections to reduce incidence and morbidity.
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS
(2021)
Article
Immunology
Ricardo Rabagliati et al.
Summary: In an academic hospital in Santiago, Chile, 11% of nonimmunocompromised severe COVID-19 patients developed COVID-19-associated invasive mold infection (CAIMI), with a mortality rate of 31.2%.
EMERGING INFECTIOUS DISEASES
(2021)
Letter
Ophthalmology
Sandip Sarkar et al.
INDIAN JOURNAL OF OPHTHALMOLOGY
(2021)
Article
Medicine, General & Internal
Shweta Mallikarjun Revannavar et al.
Summary: This case report describes a rare case of mucormycosis in a middle-aged woman with non-ketotic diabetes and COVID-19, presenting with orbital apex syndrome, brain infarction, and other complications. Early diagnosis and treatment are crucial for preventing further organ damage.
Article
Dentistry, Oral Surgery & Medicine
Aditya Moorthy et al.
Summary: Analyzing data on maxillofacial/rhino-cerebro-orbital fungal infections during the Covid-19 pandemic revealed a significant increase in diabetic patients infected with SARS-CoV-2, with a strong association with corticosteroid administration. The study highlights the importance of understanding common contributing factors to such infections and the need for further research in this area.
JOURNAL OF MAXILLOFACIAL & ORAL SURGERY
(2021)
Article
Ophthalmology
Mrittika Sen et al.
Summary: COVID-19 infection, treatment, immunosuppression, and comorbidities have made patients susceptible to secondary infections such as mucormycosis. Mucormycosis is a life-threatening opportunistic infection, particularly for patients with moderate to severe COVID-19. Early diagnosis and appropriate management play a crucial role in improving survival rates.
INDIAN JOURNAL OF OPHTHALMOLOGY
(2021)
Article
Ophthalmology
Raksha Rao et al.
Summary: This case report describes a 66-year-old male with uncontrolled diabetes and systemic steroids for COVID-19 presenting with orbital infarction syndrome, with imaging findings of orbital tissue ischemia secondary to isolated ophthalmic artery obstruction. Pathological examination confirmed mucor infection. This is the first reported case of orbital infarction syndrome in the context of COVID-19.
INDIAN JOURNAL OF OPHTHALMOLOGY
(2021)
Article
Ophthalmology
Swati A. Ravani et al.
Summary: The study documented cases of rhino-orbital mucormycosis during the COVID-19 pandemic, finding that uncontrolled diabetes and COVID-19 positivity were major risk factors. Treatment with intravenous liposomal amphotericin B and debridement of necrotic tissue led to a high recovery rate, with significant factors in predicting patient survival being cerebral involvement and HbA1c value.
INDIAN JOURNAL OF OPHTHALMOLOGY
(2021)
Article
Immunology
J. Peter Donnelly et al.
CLINICAL INFECTIOUS DISEASES
(2020)
Article
Gastroenterology & Hepatology
Epifanio Silvino do Monte Junior et al.
CLINICAL ENDOSCOPY
(2020)
Article
Infectious Diseases
Brian Hanley et al.
Article
Radiology, Nuclear Medicine & Medical Imaging
Bo Da Nam et al.
EUROPEAN RADIOLOGY
(2018)
